PARA vs SRTAW · rev $5.0M vs rev $248.7M
PARA (PARA) versus Strata Critical Medical, Inc. (SRTAW) — a side-by-side from cached financials, not a winner call.
PARA (PARA) common stock.
Strata Critical Medical, Inc. (SRTAW) common stock listed on NASDAQ.
Latest reported PARA revenue for 2026-06-30 was $5.0M. Net income was -$13.4M. Revenue was up 84.3% from 2026-03-31 to 2026-06-30. PARA currently screens at market cap $0.
Latest reported SRTAW revenue for 2024-12-31 was $248.7M. Net income was -$27.3M. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. SRTAW currently screens at market cap $0.
PARA currently screens at market cap $0. SRTAW currently screens at market cap $0.
Not investment advice. Open the PARA and SRTAW stock pages for the full models.
Not investment advice.